SNAKE-VENOM COAGULOPATHY - USE AND ABUSE OF BLOOD PRODUCTS IN THE TREATMENT OF PIT VIPER ENVENOMATION

被引：21

作者：

BURGESS, JL

DART, RC

机构：

[1] Section of Emergency Medicine, University of Arizona, Tucson

[2] Arizona Poison and Drug Information Center, University of Arizona, Tucson

来源：

ANNALS OF EMERGENCY MEDICINE | 1991年 / 20卷 / 07期

关键词：

antivenin; coagulopathy; CROTALIDAE;

D O I：

10.1016/S0196-0644(05)80845-5

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Coagulopathies are commonly encountered in victims of pit viper envenomation. In the majority of patients these defects improve with administration of antivenin. However, blood products are often transfused based on arbitrary criteria and with significant risk to the patient. This article documents the effectiveness and risks of antivenin administration and the risks of blood product transfusion. We recommend that blood products not be used except for clearly defined clinical indications.

引用

页码：795 / 801

页数：7

共 42 条

[1]

Glass, Management of Poisonous Snakebite, pp. 3-7, (1976)

[2]

Russell, Snake Venom Poisoning, pp. 306-343, (1983)

[3]

Corrigan, Hemorrhagic and Thrombotic Diseases in Childhood Adolescence, pp. 188-202, (1985)

[4]

Cooke, Hampton, Sherman, Et al., Allergy induced by immunization with tetanus toxoid, JAMA, 114, pp. 1854-1858, (1940)

[5]

Facktor, Bernstein, Fireman, Hypersensitivity to tetanus toxoid, J Aller Clin Immunol, 52, pp. 1-12, (1973)

[6]

Human antitoxin in prophylaxis and treatment of tetanus, Med Lett, 7, pp. 13-14, (1965)

[7]

Spaite, Dart, Hurlbut, Et al., Skin testing: Implications in the management of pit viper envenomation, Ann Emerg Med, 17, (1988)

[8]

Christensen, Snakebite and the use of antivenin in Southern Africa, S Air Med J, 59, pp. 934-938, (1981)

[9]

Wingert, Chan, Rattlesnake bites in Southern California and rationale for recommended treatment, West J Med, 148, pp. 37-44, (1988)

[10]

Dart, Burgess, Snakebite coagulopathy, Clin Haemosr Rev, 4, (1990)

← 1 2 3 4 5 →